"PMC1887589": {
    "pmid": "17537913",
    "title": "A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity",
    "study_parameters": [
      {
        "Study Parameters ID": 748460580,
        "Variant Annotation ID": 748448812,
        "Study Type": "trios",
        "Study Cases": 87.0,
        "Study Controls": null,
        "Characteristics": "in cell lines from 30 parent-child trios",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "= 2.0E-5",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "European",
        "Variant Annotation ID_norm": "748448812"
      },
      {
        "Study Parameters ID": 981240144,
        "Variant Annotation ID": 981240140,
        "Study Type": "trios",
        "Study Cases": 177.0,
        "Study Controls": null,
        "Characteristics": "HapMap cell lines",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "< 0.05",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "Multiple groups, 88 CEU HapMap cell lines; 89 Yorubi HapMap cell lines",
        "Variant Annotation ID_norm": "981240140"
      },
      {
        "Study Parameters ID": 1452801124,
        "Variant Annotation ID": 1452801106,
        "Study Type": "trios",
        "Study Cases": 89.0,
        "Study Controls": null,
        "Characteristics": "in cell lines from 30 parent-child trios",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "= 5.0E-5",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "Sub-Saharan African",
        "Variant Annotation ID_norm": "1452801106"
      },
      {
        "Study Parameters ID": 1184136126,
        "Variant Annotation ID": 1184136124,
        "Study Type": "trios",
        "Study Cases": 89.0,
        "Study Controls": null,
        "Characteristics": "in cell lines from 30 parent-child trios",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "= 7.0E-8",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "Sub-Saharan African",
        "Variant Annotation ID_norm": "1184136124"
      },
      {
        "Study Parameters ID": 1184136130,
        "Variant Annotation ID": 1184136128,
        "Study Type": "trios",
        "Study Cases": 87.0,
        "Study Controls": null,
        "Characteristics": "in cell lines from 30 parent-child trios",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "= 7.0E-7",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "European",
        "Variant Annotation ID_norm": "1184136128"
      },
      {
        "Study Parameters ID": 981240136,
        "Variant Annotation ID": 981240132,
        "Study Type": "trios",
        "Study Cases": 177.0,
        "Study Controls": null,
        "Characteristics": "HapMap Cell lines",
        "Characteristics Type": "Study Cohort",
        "Frequency In Cases": null,
        "Allele Of Frequency In Cases": null,
        "Frequency In Controls": null,
        "Allele Of Frequency In Controls": null,
        "P Value": "= 0.03",
        "Ratio Stat Type": "Unknown",
        "Ratio Stat": null,
        "Confidence Interval Start": null,
        "Confidence Interval Stop": null,
        "Biogeographical Groups": "Multiple groups, 88 CEU HapMap cell lines; 89 Yorubi HapMap cell lines",
        "Variant Annotation ID_norm": "981240132"
      }
    ],
    "var_drug_ann": [
      {
        "Variant Annotation ID": 981240140,
        "Variant/Haplotypes": "rs446112",
        "Gene": null,
        "Drug(s)": "etoposide",
        "PMID": 17537913,
        "Phenotype Category": "Other",
        "Significance": "yes",
        "Notes": null,
        "Sentence": "Genotype AA is associated with increased resistance to etoposide as compared to genotypes AG + GG.",
        "Alleles": "AA",
        "Specialty Population": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "increased",
        "PD/PK terms": "resistance to",
        "Multiple drugs And/or": null,
        "Population types": null,
        "Population Phenotypes or diseases": null,
        "Multiple phenotypes or diseases And/or": null,
        "Comparison Allele(s) or Genotype(s)": "AG + GG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "981240140"
      },
      {
        "Variant Annotation ID": 1452801106,
        "Variant/Haplotypes": "rs2784917",
        "Gene": "SLIT1",
        "Drug(s)": "etoposide",
        "PMID": 17537913,
        "Phenotype Category": "Metabolism/PK",
        "Significance": "yes",
        "Notes": "\"Specifically, rs10061997, rs12190776, rs2784917, and rs9730073 were all significant predictors of etoposide IC50. The overall estimate of R2 = 0.40, indicates 40% of the etoposide IC50 variation can be explained by these 4 SNPs in the YRI.\"",
        "Sentence": "Genotype AA is associated with decreased inhibition of etoposide as compared to genotypes AG + GG.",
        "Alleles": "AA",
        "Specialty Population": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "decreased",
        "PD/PK terms": "inhibition of",
        "Multiple drugs And/or": null,
        "Population types": null,
        "Population Phenotypes or diseases": null,
        "Multiple phenotypes or diseases And/or": null,
        "Comparison Allele(s) or Genotype(s)": "AG + GG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "1452801106"
      }
    ],
    "var_pheno_ann": [
      {
        "Variant Annotation ID": 748448812,
        "Variant/Haplotypes": "rs6539870",
        "Gene": null,
        "Drug(s)": "etoposide",
        "PMID": 17537913,
        "Phenotype Category": "Other",
        "Significance": "yes",
        "Notes": null,
        "Sentence": "Genotype GG is associated with increased sensitivity to etoposide when exposed to etoposide as compared to genotypes AA + AG.",
        "Alleles": "GG",
        "Specialty Population": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "increased",
        "Side effect/efficacy/other": null,
        "Phenotype": "Other:sensitivity to etoposide",
        "Multiple phenotypes And/or": null,
        "When treated with/exposed to/when assayed with": "when exposed to",
        "Multiple drugs And/or": null,
        "Population types": null,
        "Population Phenotypes or diseases": null,
        "Multiple phenotypes or diseases And/or": null,
        "Comparison Allele(s) or Genotype(s)": "AA + AG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "748448812"
      }
    ],
    "var_fa_ann": [
      {
        "Variant Annotation ID": 1184136124,
        "Variant/Haplotypes": "rs2784917",
        "Gene": null,
        "Drug(s)": null,
        "PMID": 17537913,
        "Phenotype Category": "Other",
        "Significance": "yes",
        "Notes": null,
        "Sentence": "Genotype AA is associated with increased expression of WNT5B as compared to genotypes AG + GG.",
        "Alleles": "AA",
        "Specialty Population": null,
        "Assay type": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "increased",
        "Functional terms": "expression of",
        "Gene/gene product": "WNT5B",
        "When treated with/exposed to/when assayed with": null,
        "Multiple drugs And/or": null,
        "Cell type": null,
        "Comparison Allele(s) or Genotype(s)": "AG + GG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "1184136124"
      },
      {
        "Variant Annotation ID": 1184136128,
        "Variant/Haplotypes": "rs6539870",
        "Gene": null,
        "Drug(s)": null,
        "PMID": 17537913,
        "Phenotype Category": "Other",
        "Significance": "yes",
        "Notes": null,
        "Sentence": "Genotype GG is associated with increased expression of IL1B as compared to genotypes AA + AG.",
        "Alleles": "GG",
        "Specialty Population": null,
        "Assay type": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "increased",
        "Functional terms": "expression of",
        "Gene/gene product": "IL1B",
        "When treated with/exposed to/when assayed with": null,
        "Multiple drugs And/or": null,
        "Cell type": null,
        "Comparison Allele(s) or Genotype(s)": "AA + AG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "1184136128"
      },
      {
        "Variant Annotation ID": 981240132,
        "Variant/Haplotypes": "rs446112",
        "Gene": null,
        "Drug(s)": null,
        "PMID": 17537913,
        "Phenotype Category": "Other",
        "Significance": "yes",
        "Notes": null,
        "Sentence": "Genotype AA is associated with increased expression of AGPAT2 as compared to genotypes AG + GG.",
        "Alleles": "AA",
        "Specialty Population": null,
        "Assay type": null,
        "Metabolizer types": null,
        "isPlural": "Is",
        "Is/Is Not associated": "Associated with",
        "Direction of effect": "increased",
        "Functional terms": "expression of",
        "Gene/gene product": "AGPAT2",
        "When treated with/exposed to/when assayed with": null,
        "Multiple drugs And/or": null,
        "Cell type": null,
        "Comparison Allele(s) or Genotype(s)": "AG + GG",
        "Comparison Metabolizer types": null,
        "PMID_norm": "17537913",
        "Variant Annotation ID_norm": "981240132"
      }
    ]
  },